Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP472343.RA3lNGq--4oaHRHooldhqnQBvABp14XIYw9rP0vQ9jox4130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP472343.RA3lNGq--4oaHRHooldhqnQBvABp14XIYw9rP0vQ9jox4130_assertion type Assertion NP472343.RA3lNGq--4oaHRHooldhqnQBvABp14XIYw9rP0vQ9jox4130_head.
- NP472343.RA3lNGq--4oaHRHooldhqnQBvABp14XIYw9rP0vQ9jox4130_assertion description "[Therapeutic targeting of Oct4(+)/TNC(+) progenitors may counteract the contribution of NB-derived ECs to tumor relapse and chemoresistance.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP472343.RA3lNGq--4oaHRHooldhqnQBvABp14XIYw9rP0vQ9jox4130_provenance.
- NP472343.RA3lNGq--4oaHRHooldhqnQBvABp14XIYw9rP0vQ9jox4130_assertion evidence source_evidence_literature NP472343.RA3lNGq--4oaHRHooldhqnQBvABp14XIYw9rP0vQ9jox4130_provenance.
- NP472343.RA3lNGq--4oaHRHooldhqnQBvABp14XIYw9rP0vQ9jox4130_assertion SIO_000772 21403679 NP472343.RA3lNGq--4oaHRHooldhqnQBvABp14XIYw9rP0vQ9jox4130_provenance.
- NP472343.RA3lNGq--4oaHRHooldhqnQBvABp14XIYw9rP0vQ9jox4130_assertion wasDerivedFrom befree-20150227 NP472343.RA3lNGq--4oaHRHooldhqnQBvABp14XIYw9rP0vQ9jox4130_provenance.
- NP472343.RA3lNGq--4oaHRHooldhqnQBvABp14XIYw9rP0vQ9jox4130_assertion wasGeneratedBy ECO_0000203 NP472343.RA3lNGq--4oaHRHooldhqnQBvABp14XIYw9rP0vQ9jox4130_provenance.